Genetic and mechanistic dissection of a lethal systemic virus infection

致命性全身病毒感染的遗传学和机制剖析

基本信息

项目摘要

 DESCRIPTION (provided by applicant): Systemic virus infections cause significant morbitity and mortality and are a significant worldwide health problem. People vary in disease outcome, and this is partly due to natural allelic variation throughout the genome. We are interested in better understanding how genomic elements outside of the MHC, TCR, and immunoglobulin regions regulate pathogenic outcomes to infection. The mouse arenavirus, LCMV-clone13, rapidly disseminates upon infection and causes limited pathogenesis in C57B6 mice. We have identified a substrain of B6 mouse that develops many characteristics of viral hemmoragic fever and systemic shock following infection, including severe weight loss, excessive cytokine production, and evidence of elevated tissue damage. These two strains are ~98% identical, but we have identified a 30Mb stretch on Chromosome 9 that and associates with the severe phenotype. The disease causing locus is dominantly inherited in F1 crosses and 100% penetrant. We hypothesize that the severe pathogenesis is caused by a single, gain-of-function gene in this region that exaggerates the antiviral T cell response. Here, we propose to identify the genetic mutation that causes severe pathogenesis after infection. The objectives of Aim1 are to use forward genetics coupled with bioinformatic approaches to narrow the disease-causing QTL to identify a small number of genes. We will examine whether genes within this interval are differentially expressed and whether there are global gene expression changes in T cells. The objectives of Aim2 are to determine whether the disease-causing genotype needs to be expressed by hematopoietic or non- hematopoietic cells to cause severe pathogenesis. Overall, this project will identify genetic loci that cause severe pathogenesis after systemic viru infection. These efforts will support a long-term endeavor to identify and characterize genetic elements that increase susceptibility to virus infection. This information is valuable for identifyng individuals at increased risk of disease after virus infection and for developing therapeutics to prevent severe pathogenesis following systemic virus infection.
 描述(由申请方提供):全身性病毒感染导致显著的发病率和死亡率,是一个严重的全球性健康问题。人们的疾病结果各不相同,这部分是由于整个基因组中的天然等位基因变异。我们有兴趣更好地了解MHC,TCR和免疫球蛋白区域以外的基因组元件如何调节感染的致病结果。小鼠沙粒病毒LCMV-克隆13在感染后迅速传播,并在C57 B6小鼠中引起有限的发病机制。我们已经确定了B6小鼠的一个亚系,该亚系在感染后出现病毒性出血热和全身性休克的许多特征,包括严重的体重减轻、过度的细胞因子产生和组织损伤升高的证据。这两个菌株约98%相同,但我们已经确定了9号染色体上的30 Mb延伸,并与严重表型相关。致病位点在F_1中为显性遗传,100%外显。我们推测,严重的发病机制是由该区域的一个单一的功能获得性基因引起的,该基因夸大了抗病毒T细胞的反应。在这里,我们建议确定感染后导致严重发病的基因突变。Aim 1的目标是使用正向遗传学结合生物信息学方法来缩小致病QTL的范围,以识别少量基因。我们将研究在此区间内的基因是否差异表达,以及T细胞中是否存在全局基因表达变化。Aim 2的目的是确定致病基因型是否需要由造血细胞或非造血细胞表达以引起严重的发病机制。总的来说,本项目将确定系统性维鲁感染后导致严重发病的遗传位点。这些努力将支持一项长期奋进,以确定和表征增加病毒感染易感性的遗传因素。这些信息对于识别病毒感染后疾病风险增加的个体和开发治疗方法以预防系统性病毒感染后的严重发病机制是有价值的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JASON Kyle WHITMIRE其他文献

JASON Kyle WHITMIRE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JASON Kyle WHITMIRE', 18)}}的其他基金

Regulation of CD8+ T cell responses to chronic virus infection
CD8 T 细胞对慢性病毒感染反应的调节
  • 批准号:
    10551313
  • 财政年份:
    2019
  • 资助金额:
    $ 19万
  • 项目类别:
Regulation of CD8+ T cell responses to chronic virus infection
CD8 T 细胞对慢性病毒感染反应的调节
  • 批准号:
    10330570
  • 财政年份:
    2019
  • 资助金额:
    $ 19万
  • 项目类别:
Obesity associated viral pathogenesis
肥胖相关的病毒发病机制
  • 批准号:
    10455596
  • 财政年份:
    2018
  • 资助金额:
    $ 19万
  • 项目类别:
Obesity associated viral pathogenesis
肥胖相关的病毒发病机制
  • 批准号:
    10231137
  • 财政年份:
    2018
  • 资助金额:
    $ 19万
  • 项目类别:
Genetic and mechanistic dissection of a lethal systemic virus infection
致命性全身病毒感染的遗传学和机制剖析
  • 批准号:
    9100642
  • 财政年份:
    2015
  • 资助金额:
    $ 19万
  • 项目类别:
NK cell regulation of adaptive immunity during persisting virus infection
持续病毒感染期间 NK 细胞对适应性免疫的调节
  • 批准号:
    8891633
  • 财政年份:
    2014
  • 资助金额:
    $ 19万
  • 项目类别:
Analyses of the effects of pro-inflammatory cytokines on CD4+ T cell responses
促炎细胞因子对 CD4 T 细胞反应的影响分析
  • 批准号:
    7653812
  • 财政年份:
    2008
  • 资助金额:
    $ 19万
  • 项目类别:
Analyses of the effects of pro-inflammatory cytokines on CD4+ T cell responses
促炎细胞因子对 CD4 T 细胞反应的影响分析
  • 批准号:
    8081812
  • 财政年份:
    2008
  • 资助金额:
    $ 19万
  • 项目类别:
Analyses of the effects of pro-inflammatory cytokines on CD4+ T cell responses
促炎细胞因子对 CD4 T 细胞反应的影响分析
  • 批准号:
    7898905
  • 财政年份:
    2008
  • 资助金额:
    $ 19万
  • 项目类别:
Analyses of the effects of pro-inflammatory cytokines on CD4+ T cell responses
促炎细胞因子对 CD4 T 细胞反应的影响分析
  • 批准号:
    8059352
  • 财政年份:
    2008
  • 资助金额:
    $ 19万
  • 项目类别:

相似海外基金

Development of a new generation of antiviral agents that are effective against drug-resistant viruses and prevent serious illness and sequelae.
开发新一代抗病毒药物,可有效对抗耐药病毒并预防严重疾病和后遗症。
  • 批准号:
    23K18186
  • 财政年份:
    2023
  • 资助金额:
    $ 19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
A versatile structure-based therapeutic platform for development of VHH-based antitoxin and antiviral agents
一个多功能的基于结构的治疗平台,用于开发基于 VHH 的抗毒素和抗病毒药物
  • 批准号:
    10560883
  • 财政年份:
    2023
  • 资助金额:
    $ 19万
  • 项目类别:
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10730692
  • 财政年份:
    2021
  • 资助金额:
    $ 19万
  • 项目类别:
Design and synthesis of nucleosides to develop antiviral agents and oligonucleotide therapeutics
设计和合成核苷以开发抗病毒药物和寡核苷酸疗法
  • 批准号:
    21K06459
  • 财政年份:
    2021
  • 资助金额:
    $ 19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Genetically encoded bicyclic peptide libraries for the discoveryof novel antiviral agents
用于发现新型抗病毒药物的基因编码双环肽库
  • 批准号:
    10189880
  • 财政年份:
    2021
  • 资助金额:
    $ 19万
  • 项目类别:
Computer-aided identification and synthesis of novel broad-spectrum antiviral agents
新型广谱抗病毒药物的计算机辅助鉴定和合成
  • 批准号:
    2404261
  • 财政年份:
    2020
  • 资助金额:
    $ 19万
  • 项目类别:
    Studentship
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10222540
  • 财政年份:
    2020
  • 资助金额:
    $ 19万
  • 项目类别:
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10669717
  • 财政年份:
    2020
  • 资助金额:
    $ 19万
  • 项目类别:
Association between sedentary lifestyle and liver cancer development in hepatitis C patients treated with direct-acting antiviral agents
接受直接抗病毒药物治疗的丙型肝炎患者久坐的生活方式与肝癌发展之间的关系
  • 批准号:
    20K10713
  • 财政年份:
    2020
  • 资助金额:
    $ 19万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Develop broad-spectrum antiviral agents against COVID-19 based on innate immune response to SARS-CoV-2 infection
基于对 SARS-CoV-2 感染的先天免疫反应,开发针对 COVID-19 的广谱抗病毒药物
  • 批准号:
    10174522
  • 财政年份:
    2020
  • 资助金额:
    $ 19万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了